Yunnan Green Wild Biopharmaceutical

Yunnan Green Wild Biopharmaceutical is a specialized pharmaceutical company based in Kunming, China, focusing on the development and commercialization of botanical medicines derived from the Yunnan-Guizhou Plateau's unique flora. The company is a prominent leader in the production of Erigeron breviscapus (Dengzhanhua) preparations, which are integral to Traditional Chinese Medicine for treating cardiovascular and cerebrovascular ailments. Its flagship products include Dengzhan Xixin injections and oral formulations, which are widely utilized in clinical settings to manage ischemic stroke, cerebral infarction, and coronary heart disease. Yunnan Green Wild operates advanced, GMP-certified manufacturing facilities that emphasize standardized extraction and purification processes to ensure product quality and safety. By bridging traditional herbal knowledge with modern pharmaceutical standards, the company has established a significant presence in the Chinese domestic market for natural cardiovascular therapies.